Skip to content

Price / sales at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
2.6×-0.1×
Gilead Sciences logo
Gilead SciencesGILD
5.8×+1.0×
Immunome logo
ImmunomeIMNM
616.2×+563×
Nuvation Bio logo
Nuvation BioNUVB
10.4×-44.0×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
56.2×-26.1×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
28.2×-3,609×

Other financials

Income statement

See full
Revenue$71.4M+44.8%
Gross profit$28.9M+338%
Operating income-$81.0M+33.1%
Net income-$79.0M+32.0%
EPS (diluted)-$0.19+47.2%

Balance sheet

See full
Cash & equivalents$196.5M+14.5%
Total debt$46.8M-11.3%
Total equity$721.8M-6.0%
Total assets$925.7M-4.2%

Cash flow

See full
Operating cash flow-$72.1M+30.5%
CapEx$6.6M+6.4%
Free cash flow-$78.7M+28.4%

Valuation

See full
Market cap$1.98B+32.4%
Enterprise value$1.83B+33.2%

Profitability

See full
Gross margin36.7%+4.1pp
Operating margin-127.2%-31.0pp
Net margin-123.9%-28.4pp
FCF margin-106.8%-27.5pp

Returns & leverage

See full
Return on equity-47.5%-3.7pp
Debt / equity0.1×0.0×
Current ratio3.6×-0.6×

Where this comes from

Calculated from Iovance Biotherapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s price / sales?
Iovance Biotherapeutics, Inc. (IOVA) reported price / sales of 5.1× in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s price / sales changed year-over-year?
Iovance Biotherapeutics, Inc.'s price / sales decreased by 1.4% year-over-year, from 5.1× to 5.1×.
What is the long-term trend for Iovance Biotherapeutics, Inc.'s price / sales?
Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s price / sales has grown at a -95.2% compound annual growth rate (CAGR), from 1,750.1× to 4.1×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.